FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:1872-1873 November 1, 2007 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

To the Editor: In their letter to the editor, Budach et al. (Aug. 2 issue)¹ report on two patients with squamous-cell carcinoma of the head and neck who had severe radiation dermatitis while receiving a combination of radiotherapy and cetuximab, a regimen found to be superior to radiotherapy alone in our proof-of-concept phase 3 trial.² Severe radiation dermatitis can occur after irradiation alone, but grade 4 dermatitis is rarely observed. In reviewing the case histories of the patients, Budach et al. note that Patient 1 had previously received etoposide-based therapy and Patient 2 had previously received a full course of . . . [Full Text of this Article]

Related Letters:

Severe Cutaneous Reaction during Radiation Therapy with Concurrent Cetuximab
Budach W., Bölke E., Homey B.
Extract | Full Text | PDF  
N Engl J Med 2007; 357:514-515, Aug 2, 2007. Correspondence

This article has been cited by other articles:

• Jatoi, A., Nguyen, P. L. (2008). Do Patients Die from Rashes from Epidermal Growth Factor Receptor Inhibitors? A Systematic Review to Help Counsel Patients About Holding Therapy. The Oncologist 13: 1201-1204 [Abstract] [Full Text]